Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review

Cardiovascular disease and the biology of aging - Journal of Molecular and Cellular Cardiology

Protease Inhibitors And Cardiovascular Outcomes In Patients, 60% OFF

Protease Inhibitors And Cardiovascular Outcomes In Patients, 60% OFF

Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management

Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review - ScienceDirect

Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease. - Abstract - Europe PMC

Cells, Free Full-Text

Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review - ScienceDirect

Frontiers Atrial Cardiomyopathy Predicts Worse Outcome in Patients With Lung Cancer

Biomolecules, Free Full-Text

Frontiers Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction

Novel metabolic biomarkers of cardiovascular disease

Galectin-3 - Wikipedia

Cells, Free Full-Text